SWOG S1512 Primary Category: Treatment Protocols Disease Category: Melanoma, Skin Status: Open A Phase II and Pilot Trial of PD-1 Blockade with MK-3475 (Pembrolizumab) in Patients with Resectable or Unresectable Desmoplastic Melanoma (DM) NCT#02775851 (Click for More Info)